AMENDMENT NO. 2 TO THE AMALGAMATION AGREEMENTAmalgamation Agreement • April 27th, 2018 • Sinovac Biotech LTD • Pharmaceutical preparations
AMENDMENT NO. 2 TO AMALGAMATION AGREEMENT (this “Amendment”), dated as of April 26, 2018, among Sinovac (Cayman) Limited, an exempted company incorporated with limited liability under the laws of the Cayman Islands (“Parent”), Sinovac Amalgamation Sub Limited, an international business corporation incorporated under the laws of Antigua and Barbuda and a wholly-owned subsidiary of Parent (“Amalgamation Sub”), and Sinovac Biotech Ltd., a company limited by shares incorporated under the laws of Antigua and Barbuda (the “Company”). Parent, Amalgamation Sub and the Company may hereafter be referred to as a “Party” in their individual capacities and as “Parties” collectively.
